BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
1045 results:

  • 1. cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
    Cunningham R; Stanley J; Imlach F; Haitana T; Lockett H; Every-Palmer S; Clark MTR; Lacey C; Telfer K; Peterson D
    BMC Cancer; 2024 Apr; 24(1):546. PubMed ID: 38689242
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With breast cancer.
    Bhimani J; O'Connell K; Ergas IJ; Foley M; Gallagher GB; Griggs JJ; Heon N; Kolevska T; Kotsurovskyy Y; Kroenke CH; Laurent CA; Liu R; Nakata KG; Persaud S; Rivera DR; Roh JM; Tabatabai S; Valice E; Bowles EJA; Bandera EV; Kushi LH; Kantor ED
    JCO Clin Cancer Inform; 2024 Apr; 8():e2300209. PubMed ID: 38635936
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
    Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
    [No Abstract]    [Full Text] [Related]  

  • 4. Medical Home Implementation and Follow-Up of cancer-Related Abnormal Test Results in the Veterans Health Administration.
    Rajan SS; Sarvepalli S; Wei L; Meyer AND; Murphy DR; Choi DT; Singh H
    JAMA Netw Open; 2024 Mar; 7(3):e240087. PubMed ID: 38483392
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Validation of artificial intelligence contrast mammography in diagnosis of breast cancer: Relationship to histopathological results.
    Helal M; Khaled R; Alfarghaly O; Mokhtar O; Elkorany A; Fahmy A; El Kassas H
    Eur J Radiol; 2024 Apr; 173():111392. PubMed ID: 38428255
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysis.
    Ben-Zion Berliner M; Yust-Katz S; Lavie I; Goldberg Y; Kedar I; Yerushalmi R
    BMC Cancer; 2024 Feb; 24(1):219. PubMed ID: 38365640
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. breast cancer in a Hispanic patient with Werner syndrome.
    Santos MM; Baerga CG; Lamsal S; Engel C; Ozdemir S
    J Radiol Case Rep; 2023 Oct; 17(10):21-31. PubMed ID: 38343885
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
    Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
    Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.
    Abrahão R; Brunson A; Chubak J; Wernli KJ; Nichols HB; Chao C; Ruddy KJ; Hahn EE; Li Q; Malogolowkin MH; Sauder CAM; Kushi LH; Wun T; Keegan THM
    Thromb Res; 2024 Mar; 235():1-7. PubMed ID: 38244373
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
    Chang ET; Clarke CA; Colditz GA; Kurian AW; Hubbell E
    Cancer Causes Control; 2024 May; 35(5):849-864. PubMed ID: 38238615
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Characteristics and post-metastasis survival of recurrent metastatic breast cancer over time - An Australian population-based record linkage study, 2001-2016.
    Lord SJ; Kiely BE; O'Connell DL; Daniels B; Beith J; Smith AL; Pearson SA; Chiew KL; Bulsara MK; Houssami N
    Eur J Cancer; 2024 Jan; 197():113468. PubMed ID: 38061215
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study.
    Digkas E; Smith DR; Wennstig AK; Matikas A; Tegnelius E; Valachis A
    Breast Cancer Res Treat; 2024 Feb; 204(1):79-87. PubMed ID: 38057688
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical, Pathological, and Prognostic Features of Male breast cancer: A Multicenter Study.
    Accomasso F; Actis S; Minella C; Rosso R; Granaglia C; Ponzone R; Biglia N; Bounous VE
    Curr Oncol; 2023 Nov; 30(11):9860-9871. PubMed ID: 37999136
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
    Zhang H; Yang Y; Xing W; Li Y; Zhang S
    BMC Cancer; 2023 Nov; 23(1):1124. PubMed ID: 37978469
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
    Carter MM; Whitrock JN; Pratt CG; Shaughnessy EA; Meier TM; Barrord MF; Hanseman DJ; Reyna CR; Heelan AA; Lewis JD
    Ann Surg Oncol; 2024 Mar; 31(3):1599-1607. PubMed ID: 37978114
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Characteristics of early short-term traditional Chinese medicine in breast cancer patients: A population-based cohort study.
    Chan PW; Yu H; Hsu CH; Liu CY
    J Chin Med Assoc; 2024 Jan; 87(1):70-78. PubMed ID: 37962411
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of the age of onset of metabolic syndrome with the risk of all cancer types.
    Liu T; Liu CA; Zhang QS; Zhang Q; Wang YM; Song MM; Lin SQ; Deng L; Wu SL; Shi HP
    Diabetes Metab Syndr; 2023 Nov; 17(11):102896. PubMed ID: 37913630
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
    Zhao YY; Ge HJ; Yang WT; Shao ZM; Hao S
    Breast Cancer Res Treat; 2024 Feb; 203(3):543-551. PubMed ID: 37897648
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. cancer incidence in the US military: An updated analysis.
    Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
    Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis.
    Lee I; Luo Y; Carretta H; LeBlanc G; Sinha D; Rust G
    Cancer Causes Control; 2024 Feb; 35(2):253-263. PubMed ID: 37702967
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 53.